| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.29 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.06 |